ADHD-like behavior in a patient with hypothalamic hamartoma

作者：Katayama Koujyu; Yamashita Yushiro^*; Yatsuga Shuichi; Koga Yasutoshi; Matsuishi Toyojiro

来源：Brain & Development, 2016, 38(1): 145-148.

DOI：10.1016/j.braindev.2015.05.011

• Attention deficit hyperactivity disorder
• Central precocious puberty
• Hypothalamic hamartoma
• Conduct disorder
• Gonadotropin-releasing hormone analogue

We report a male patient with hypothalamic hamartoma (HH) who manifested central precocious puberty (CPP) at 4 years of age. Gonadotropin-releasing hormone (GnRH) analogue treatment was started at 6 years of age and his pubertal signs were suppressed. At 9 years of age, the patient was emotionally unstable, aggressive, and antisocial. He had severe attention deficit hyperactivity disorder (ADHD)-like behavior and conduct disorder. No seizure activity was observed. GnRH analogue treatment was discontinued for 8 months from 9 years and 4 months of age due to his mother's illness. During this period sexual urges were observed. Treatment with daily methylphenidate markedly improved his behavioral problems. However, his sexual urges were not suppressed until 3 months after the GnRH analogue treatment was restarted. The present case is unique because the patient's behavioral problems were observed despite the parahypothalamic type of HH and absence of seizures. This case is also rare because behavioral problems were observed without seizures, and no ADHD cases with hamartoma have been reported previously. Recently, clinical studies have described an association between psychiatric morbidity, including ADHD, and hyperandrogenism disorders. Our patient's ADHD-like symptoms might be due to hyperandrogenism. In such cases, GnRH analogue with methylphenidate could be effective for improving ADHD-like symptoms.

• 出版日期2016-1